An Automated Molecular Point of Care Testing Device for Rapid Detection of SARS-CoV-2 and New Variants

用于快速检测 SARS-CoV-2 和新变种的自动化分子护理点测试设备

• 批准号: 448947
• 负责人: Mahshid Sara
• 金额: $ 23.31万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-04-01 至 2022-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=448947&lang=en
• 关键词: Detection Of New Variants; Molecular Detection Of Sars-Cov-2; Point Of Care Diagnostics; Rna-Based Covid-19 Test

Since the beginning of COVID-19 pandemic in March 2020, over 130,000,000 confirmed cases and 3,000,000 deaths have been identified. The shortage of approved low cost rapid diagnostic tests has inhibited the testing of individuals with mild or hidden sympt

自2020年3月COVID-19大流行开始以来，已确认超过130，000，000例确诊病例及3，000，000例死亡病例。由于缺乏经批准的低成本快速诊断测试，抑制了对具有轻度或隐性症状的个体的测试。